Analyst Ratings For NASDAQ:CYTX – Cytori Therapeutics (NASDAQ:CYTX)
Today, HC Wainwright initiated coverage on NASDAQ:CYTX – Cytori Therapeutics (NASDAQ:CYTX) with a Buy with a price target of $4.00.
Some recent analyst ratings include
- 5/7/2018-HC Wainwright initiated coverage with a Buy rating.
- 3/9/2018-B. Riley Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
- 2/22/2018-Laidlaw Reiterated Rating of Buy ➝ Buy.
- 6/28/2016-Roth Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:CYTX – Cytori Therapeutics (NASDAQ:CYTX)
NASDAQ:CYTX – Cytori Therapeutics (NASDAQ:CYTX) has insider ownership of 0.80% and institutional ownership of 5.92%.
- On 2/13/2018 Ag Postfinance, Major Shareholder, sold 286,982 with an average share price of $0.31 per share and the total transaction amounting to $88,964.42.
- On 2/9/2018 Ag Postfinance, Major Shareholder, sold 236,155 with an average share price of $0.34 per share and the total transaction amounting to $80,292.70.
- On 1/11/2018 Bank Sa Swissquote, Major Shareholder, sold 72,630 with an average share price of $0.34 per share and the total transaction amounting to $24,694.20.
- On 1/9/2018 Bank Sa Swissquote, Major Shareholder, sold 100,000 with an average share price of $0.38 per share and the total transaction amounting to $38,000.00.
- On 8/10/2016 John David Harris, VP, bought 2,500 with an average share price of $2.03 per share and the total transaction amounting to $5,075.00.
- On 6/14/2016 Gail K Naughton, Director, bought 1,000 with an average share price of $2.10 per share and the total transaction amounting to $2,100.00.
- On 5/13/2016 John David Harris, VP, bought 2,000 with an average share price of $2.71 per share and the total transaction amounting to $5,420.00.
Recent Trading Activity for NASDAQ:CYTX – Cytori Therapeutics (NASDAQ:CYTX)
Shares of NASDAQ:CYTX – Cytori Therapeutics closed the previous trading session at 0.26 up +0.02 7.31% with 0.25929999351501465 shares trading hands.